Skip Nav Destination
Issues
1 August 2009
-
Cover Image
Cover Image
A tissue microarray core from a patient with castration-resistant prostate cancer, obtained by transurethral resection of prostate. The core was used for detection of PTEN by fluorescent in situ hybridization. For further details please see the article by Sarker and colleagues beginning on page 4799. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
CCR Translations
Molecular Pathways
Review
Human Cancer Biology
Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells
Yu-Quan Xiong; Hui-Chuan Sun; Wei Zhang; Xiao-Dong Zhu; Peng-Yuan Zhuang; Ju-Bo Zhang; Lu Wang; Wei-zhong Wu; Lun-Xiu Qin; Zhao-You Tang
Cancer Therapy: Preclinical
2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells
Bianca Altvater; Silke Landmeier; Sibylle Pscherer; Jaane Temme; Katharina Schweer; Sareetha Kailayangiri; Dario Campana; Heribert Juergens; Martin Pule; Claudia Rossig
The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of c-Met and Epidermal Growth Factor Receptor Inhibitors in Non–small Cell Lung Cancer Cells
Shawn A. Milligan; Patrick Burke; David T. Coleman; Rebecca L. Bigelow; Joshua J. Steffan; Jennifer L. Carroll; Briana Jill Williams; James A. Cardelli
Imaging, Diagnosis, Prognosis
Cancer Therapy: Clinical
Functional Unresponsiveness and Replicative Senescence of Myeloid Leukemia Antigen–specific CD8+ T Cells After Allogeneic Stem Cell Transplantation
Gregory L. Beatty; Jasmine S. Smith; Ran Reshef; Kunal P. Patel; Theresa A. Colligon; Barbara A. Vance; Noelle V. Frey; F. Brad Johnson; David L. Porter; Robert H. Vonderheide
Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer
Andrea Fontana; Luca Galli; Anna Fioravanti; Paola Orlandi; Costanza Galli; Lorenza Landi; Simona Bursi; Giacomo Allegrini; Eloise Fontana; Roberta Di Marsico; Andrea Antonuzzo; Manolo D'Arcangelo; Romano Danesi; Mario Del Tacca; Alfredo Falcone; Guido Bocci
Autologous Melanoma Vaccine Induces Antitumor and Self-Reactive Immune Responses That Affect Patient Survival and Depend on MHC Class II Expression on Vaccine Cells
Michal Lotem; Arthur Machlenkin; Tamar Hamburger; Aviram Nissan; Luna Kadouri; Shoshana Frankenburg; Zvi Gimmon; Orit Elias; Inna Ben David; Anna Kuznetz; Eitan Shiloni; Tamar Peretz
A First-in-Man Phase I and Pharmacokinetic Study on CHR-2797 (Tosedostat), an Inhibitor of M1 Aminopeptidases, in Patients with Advanced Solid Tumors
Alison H.M. Reid; Andrew Protheroe; Gerhardt Attard; Nikki Hayward; Laura Vidal; James Spicer; Heather M. Shaw; Elizabeth A. Bone; Joanne Carter; Leon Hooftman; Adrian Harris; Johann S. De Bono
Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine with Aldesleukin (Interleukin 2) and IFN-α2a Therapy in Metastatic Renal Cell Carcinoma Patients
Thomas Schwaab; Adrian Schwarzer; Benita Wolf; Todd S. Crocenzi; John D. Seigne; Nancy A. Crosby; Bernard F. Cole; Jan L. Fisher; Jill C. Uhlenhake; Diane Mellinger; Cathy Foster; Zbigniew M. Szczepiorkowski; Susan M. Webber; Alan R. Schned; Robert D. Harris; Richard J. Barth, Jr.; John A. Heaney; Randolph J. Noelle; Marc S. Ernstoff
Dynamic Contrast-enhanced Magnetic Resonance Imaging as a Predictor of Clinical Outcome in Canine Spontaneous Soft Tissue Sarcomas Treated with Thermoradiotherapy
Benjamin L. Viglianti; Michael Lora-Michiels; Jeanie M. Poulson; Lan Lan; Dahio Yu; Linda Sanders; Oana Craciunescu; Zeljko Vujaskovic; Donald E. Thrall; James MacFall; Cecil H. Charles; Terence Wong; Mark W. Dewhirst
Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes
Maria Teresa Voso; Valeria Santini; Carlo Finelli; Pellegrino Musto; Enrico Pogliani; Emanuele Angelucci; Giuseppe Fioritoni; Giuliana Alimena; Luca Maurillo; Agostino Cortelezzi; Francesco Buccisano; Marco Gobbi; Lorenza Borin; Anna Di Tucci; Gina Zini; Maria Concetta Petti; Giovanni Martinelli; Emiliano Fabiani; Paola Fazi; Marco Vignetti; Alfonso Piciocchi; Vincenzo Liso; Sergio Amadori; Giuseppe Leone
Susceptibility and Prevention
Sequence Variant Discovery in DNA Repair Genes from Radiosensitive and Radiotolerant Prostate Brachytherapy Patients
Trevor J. Pugh; Mira Keyes; Lorena Barclay; Allen Delaney; Martin Krzywinski; Dallas Thomas; Karen Novik; Cindy Yang; Alexander Agranovich; Michael McKenzie; W. Jim Morris; Peggy L. Olive; Marco A. Marra; Richard A. Moore
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds